- This event has passed.
TCR-based Therapies Summit
June 8, 2021 - June 10, 2021
The TCR-based Therapies Summit is Dedicated to Supercharging TCR Design, Translation & Manufacturing Strategy for Solid Tumor Success
Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density & binding affinity for solid tumor indications.
This June (8-10), join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, as we discuss how to how to overcome on-target off-tumor toxicity, enhance the binding affinity and avidity of TCR-T therapies and utilize dual targeting and combination approaches for enhanced efficacy.
Navigate across 3 days packed with dedicated, interactive formats exploring the identification of novel targets, the importance of safety profiling, and discuss optimization of soluble approaches for the development of next-generation TCR-T products.
For more details about the program, speaker faculty or pricing and discounts, download the brochure.
Helping Deliver Best-In-Class TCR Therapies
Join experts as they discuss the design, efficacy and clinical development of TCR therapeutics for solid tumor indications and beyond.
- Optimizeyour TCR therapy approach
- Explorenovel combination strategies
- Armyour cells against the hostile tumor microenvironment
- Improvetarget selection and off-target validation
- Explorethe future of manufacturing for next-generation TCRs
“Hanson Wade’s CAR-TCR summit has been already the leading specialized conference in the field – what a great suggestion to set up a dedicated forum for the rapidly growing TCR-T area.”
Steffen Walter, Chief Scientific Office, Immatics US